We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
-8.36%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.08%
AUM
$74.3B
AUM Growth
-$8.62B
(-10%)
Cap. Flow
-$532M
Cap. Flow
% of AUM
-0.72%
Top 10 Holdings %
Top 10 Hldgs %
52.32%
Holding
784
New
89
Increased
180
Reduced
401
Closed
66
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$556M |
| 2 |
NVIDIA
NVDA
|
+$117M |
| 3 |
Oracle
ORCL
|
+$104M |
| 4 |
Amazon
AMZN
|
+$79.8M |
| 5 |
Expedia Group
EXPE
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$161M |
| 2 |
Parker-Hannifin
PH
|
+$138M |
| 3 |
Cummins
CMI
|
+$94.8M |
| 4 |
Mettler-Toledo International
MTD
|
+$82.8M |
| 5 |
Home Depot
HD
|
+$77.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.44% |
| 2 | Communication Services | 20.45% |
| 3 | Consumer Discretionary | 17.53% |
| 4 | Healthcare | 11.66% |
| 5 | Industrials | 9.52% |
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2026 Portfolio in Review
As of Q1 2026, Loomis, Sayles & Company held 784 positions worth $74.3B, down 10% from $83B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Loomis, Sayles & Company's Q1 2026 filing shows 89 new, 180 increased, 401 reduced and 66 closed positions. Its largest new stake was PTC Therapeutics: 493,603 shares worth $33.6M. The largest sale was Illumina, an estimated $161M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Communication Services and Consumer Discretionary.
- Loomis, Sayles & Company's largest Q1 2026 buy was PTC Therapeutics: 493,603 shares worth $33.6M.
- Loomis, Sayles & Company added most to Booking.com in Q1 2026, an estimated $556M increase.
- Loomis, Sayles & Company's biggest Q1 2026 reduction was Illumina, cutting an estimated $161M.
- Loomis, Sayles & Company fully exited Wave Life Sciences in Q1 2026, selling an estimated $34.7M.
- Loomis, Sayles & Company's ten largest holdings make up 52% of its $74.3B portfolio in Q1 2026.
- Loomis, Sayles & Company opened 89 new positions and closed 66 in Q1 2026.
- Loomis, Sayles & Company's portfolio value fell 10% quarter-over-quarter to $74.3B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.